Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy

Jicheng Lv(Ministry of Education of the People's Republic of China), Michelle Hladunewich(Sunnybrook Health Science Centre), Ming‐Hui Zhao(China National Petroleum Corporation (China)), Laurent Billot(The George Institute for Global Health), Helen Monaghan(The George Institute for Global Health), Giuseppe Remuzzi(Mario Negri Institute for Pharmacological Research), Alan Cass(University of Sydney), Vlado Perkovic(New South Wales Department of Health), Vivekanand Jha(The George Institute for Global Health), Mark Woodward(UNSW Sydney), David W. Johnson(Hennepin County), Muh Geot Wong(FIND), Adeera Levin(University of British Columbia), Heather N. Reich(University Health Network), John Feehally(University of Leicester), Tak Mao Chan(Chinese University of Hong Kong), David C. Wheeler(University College London), Richard J. Glassock(University of California, Los Angeles), Rajiv Agarwal(Richard L. Roudebush VA Medical Center), Hong Zhang(University of Hawaiʻi at Mānoa), Hai-Yan Wang(Peking University), Meg Jardine(Royal North Shore Hospital), Yangfeng Wu(Peking University), Daniel C. Cattran(Toronto Rehabilitation Institute), Jürgen Floege(RWTH Aachen University), Sean Barbour

JAMA

August 1, 2017

Cited by 540

|Data Archiving and Networked Services (DANS)|2002|11.7k

|New England Journal of Medicine|2017|7.7k

|New England Journal of Medicine|2008|7.4k

|New England Journal of Medicine|2019|6k

|New England Journal of Medicine|2020|5.2k

Related Papers